Sort
23,748 grants matching “melanoma”
INTEGRINS AND OCULAR ANGIOGENESIS
$444,241Scripps Research Institute · R01 · FY2002 · EY
li-Key/Melanoma MHC Class II Vaccines
$444,070Antigen Express, Inc. · R43 · FY2003 · CA
Characterization of Pigmentary Disorders and Melanoma Targeting
$444,006Vincent J Hearing · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Systemic Chemotherapy of Melanoma: NMR Studies of Lonidamine & N-Mustard Activity
$443,996Jerry D Glickson · University Of Pennsylvania · R01 · FY2014 · CA
B7-H1/PD-1 modulation in cancer therapy
$443,937Drew M. Pardoll · Johns Hopkins University · R01 · FY2014 · CA
Structure-Based Design of BRAF and PI3K Inhibitors
$443,895Ronen Marmorstein · Wistar Institute · P01 · FY2012 · CA
G-protein-coupled receptor signaling in cancer development and treatment
$443,768Ramiro Iglesias-Bartolome · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Role of Formylpeptide Receptors in Host Defense
$443,620Ji Ming Wang · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Novel L-threo-sphinganines for ceramides-based cancer therapy
$443,579Barry J Maurer · Texas Tech University Health Scis Center · R15 · FY2012 · CA
Engineering diverse commensal skin bacteria for targeted immunotherapy
$443,564Yiyin Erin Chen · Broad Institute, Inc. · R21 · FY2025 · CA
Pattern recognition in medical imaging
$443,483Ilya Goldberg · National Institute On Aging · ZIC · FY2010 · AG
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model
$443,445David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · CA
Nanoscale Coordination Polymers of Cyclic-di-nucleotides and Peptide Antigens for Effective Therapy of Metastatic Colorectal Cancer
$443,412Ralph R Weichselbaum · University Of Chicago · R01 · FY2025 · CA
Coordinated Cytoskeletal Dynamics and Membrane Remodeling in Cellular Shape Change
$443,311Stephanie Gupton · Univ Of North Carolina Chapel Hill · R35 · FY2025 · GM
Study of Hepatic Arterial Infusion of Melphalan for Malignancy in the liver
$443,306Michelle Hughes · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Mechanisms of BAP1 activity in human cancer development
$443,295Michele Carbone · University Of Hawaii At Manoa · R01 · FY2022 · CA
DNA Repair, Skin Cancer and Overall Cancer Risk
$443,260Anthony J Alberg · Medical University Of South Carolina · R01 · FY2006 · CA
Developmental therapy for selectively targeting MEK-ERK pathway in cancer cells and tumor stromal compartment
$443,241Shihui Liu · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Monoclonal Antibody to FGF2 for Treatment of Hepatocellular Carcinoma and Other C
$443,212K Jin Kim · Galaxy Biotech, Llc · R44 · FY2011 · CA
The Role of Schwann Cells in the Progression of Melanoma
$443,178Yuri Bunimovich · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA
RADIORECEPTOR GUIDED SURGERY OF NEURAL CREST TUMORS
$443,059University Of Iowa · R01 · FY2000 · CA
Function of IL35+ B cells in pancreatic cancer
$443,047Yuliya Pylayeva-Gupta · Univ Of North Carolina Chapel Hill · R37 · FY2022 · CA
Using Nonclassical Estrogen Signaling to Prevent Melanoma
$442,834Todd W Ridky · University Of Pennsylvania · R01 · FY2020 · CA
Augmenting Antitumor Immunity
$442,759Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2015 · CA
Augmenting Antitumor Immunity
$442,759Hyam Isaac Levitsky · Johns Hopkins University · P01 · FY2016 · CA